Unibios Holdings S.A. (ATH:BIOSK)
2.940
-0.020 (-0.68%)
At close: Dec 5, 2025
Unibios Holdings Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 15.31 | 14.72 | 12.98 | 11.24 | 8.48 | 7.3 | Upgrade
|
| Revenue Growth (YoY) | 12.60% | 13.41% | 15.41% | 32.63% | 16.14% | -12.47% | Upgrade
|
| Cost of Revenue | 9.19 | 8.85 | 8.09 | 7.05 | 5.36 | 4.6 | Upgrade
|
| Gross Profit | 6.12 | 5.87 | 4.89 | 4.19 | 3.12 | 2.7 | Upgrade
|
| Selling, General & Admin | 3.38 | 3.5 | 3.05 | 2.95 | 2.51 | 2.39 | Upgrade
|
| Research & Development | 0.12 | 0.12 | 0.1 | - | - | - | Upgrade
|
| Other Operating Expenses | -0.1 | -0.1 | -0.07 | -0.09 | -0.12 | -0.11 | Upgrade
|
| Operating Expenses | 3.6 | 3.72 | 3.21 | 2.86 | 2.39 | 2.28 | Upgrade
|
| Operating Income | 2.52 | 2.15 | 1.68 | 1.34 | 0.72 | 0.42 | Upgrade
|
| Interest Expense | -0.39 | -0.35 | -0.62 | -0.39 | -0.37 | -0.39 | Upgrade
|
| Interest & Investment Income | 0.03 | 0.02 | 0 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | -0.02 | -0.02 | -0.04 | 0 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | -0 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 2.15 | 1.79 | 1.04 | 0.9 | 0.35 | 0.03 | Upgrade
|
| Impairment of Goodwill | -0.4 | -0.4 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.4 | - | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.1 | 0.03 | 1.33 | 0.03 | 0.02 | 0.01 | Upgrade
|
| Other Unusual Items | -0 | 0.13 | 0.03 | 0.06 | 0.18 | 0 | Upgrade
|
| Pretax Income | 3.25 | 1.55 | 2.4 | 1 | 0.55 | 0.04 | Upgrade
|
| Income Tax Expense | 0.86 | 0.53 | 0.37 | 0.35 | 0.22 | 0.13 | Upgrade
|
| Earnings From Continuing Operations | 2.39 | 1.03 | 2.03 | 0.65 | 0.33 | -0.09 | Upgrade
|
| Net Income to Company | 2.39 | 1.03 | 2.03 | 0.65 | 0.33 | -0.09 | Upgrade
|
| Net Income | 2.39 | 1.03 | 2.03 | 0.65 | 0.33 | -0.09 | Upgrade
|
| Net Income to Common | 2.39 | 1.03 | 2.03 | 0.65 | 0.33 | -0.09 | Upgrade
|
| Net Income Growth | 19.63% | -49.40% | 211.71% | 94.85% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 17 | 17 | 17 | 16 | 5 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 17 | 17 | 16 | 5 | 16 | Upgrade
|
| Shares Change (YoY) | 14.83% | 0.87% | 6.87% | 204.21% | -67.88% | 143.98% | Upgrade
|
| EPS (Basic) | 0.14 | 0.06 | 0.12 | 0.04 | 0.06 | -0.01 | Upgrade
|
| EPS (Diluted) | 0.14 | 0.06 | 0.12 | 0.04 | 0.06 | -0.01 | Upgrade
|
| EPS Growth | 4.18% | -49.84% | 191.67% | -35.95% | - | - | Upgrade
|
| Free Cash Flow | -0.33 | -0.69 | 0.71 | -2.37 | 1.01 | -0.15 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.04 | 0.04 | -0.15 | 0.19 | -0.01 | Upgrade
|
| Gross Margin | 39.96% | 39.86% | 37.67% | 37.30% | 36.75% | 37.03% | Upgrade
|
| Operating Margin | 16.44% | 14.58% | 12.93% | 11.91% | 8.53% | 5.78% | Upgrade
|
| Profit Margin | 15.62% | 6.97% | 15.63% | 5.79% | 3.94% | -1.25% | Upgrade
|
| Free Cash Flow Margin | -2.13% | -4.66% | 5.48% | -21.06% | 11.92% | -2.04% | Upgrade
|
| EBITDA | 2.83 | 2.47 | 1.94 | 1.65 | 0.99 | 0.68 | Upgrade
|
| EBITDA Margin | 18.46% | 16.76% | 14.91% | 14.65% | 11.69% | 9.37% | Upgrade
|
| D&A For EBITDA | 0.31 | 0.32 | 0.26 | 0.31 | 0.27 | 0.26 | Upgrade
|
| EBIT | 2.52 | 2.15 | 1.68 | 1.34 | 0.72 | 0.42 | Upgrade
|
| EBIT Margin | 16.44% | 14.58% | 12.93% | 11.91% | 8.53% | 5.78% | Upgrade
|
| Effective Tax Rate | 26.35% | 33.88% | 15.58% | 34.79% | 39.47% | 316.44% | Upgrade
|
| Advertising Expenses | - | 0.05 | 0.02 | 0.06 | 0.01 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.